|
Apr 23
|
Novo Nordisk Investors Just Got Terrible News. Should You Sell the Stock?
|
|
Apr 23
|
Is Eli Lilly Stock a Buy?
|
|
Apr 22
|
Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill
|
|
Apr 22
|
Novo Nordisk (NVO) Is a Good Short-Term Pick, Wealth Manager Says
|
|
Apr 22
|
Why Novo Nordisk Stock Popped Today
|
|
Apr 22
|
Think It's Too Late to Buy Novo Nordisk? Here's the Biggest Reason Why There's Still Time.
|
|
Apr 22
|
Trending tickers: Nvidia, Tesla, Roche, Novo Nordisk and Fresnillo
|
|
Apr 22
|
Novo shares down on Eli Lilly’s positive obesity pill data
|
|
Apr 22
|
Novo Nordisk Drops on Weight-Loss Study by Rival Lilly
|
|
Apr 22
|
Is Novo Nordisk A/S (NVO) The Top Falling Stock with Unusual Volume?
|
|
Apr 21
|
Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to Note
|
|
Apr 21
|
Down 61%, Is Novo Nordisk Stock Worth Buying on the Dip?
|
|
Apr 21
|
LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study
|
|
Apr 21
|
Did Eli Lilly Just Say Checkmate to Novo Nordisk?
|
|
Apr 21
|
Can anything threaten Novo and Lilly’s obesity market dominance?
|
|
Apr 18
|
Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic’s Competition Grows
|
|
Apr 18
|
Eli Lilly Vows to Make Weight-Loss Pill in U.S. as Trump Pushes for Domestic Manufacturing
|
|
Apr 18
|
Eli Lilly jumps as results from weight-loss pill study rival competitor’s
|
|
Apr 17
|
How Eli Lilly's GLP-1 pill could transform the weight-loss space
|
|
Mar 7
|
Novo Nordisk (NVO) Stock Dips While Market Gains: Key Facts
|